Journal of Addiction Research & Therapy
天美传媒 Access
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 4859
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- 天美传媒 J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- SafetyLit
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
What does the hamilton depression rating scale measure in methamphetamine users?
5th International Conference and Exhibition on Addiction Research & Therapy
Tracy L Hellem
Montana State University College of Nursing, USA
Posters & Accepted Abstracts: J Addict Res Ther
DOI:
Abstract
The Hamilton Depression Rating Scale (HAMD) is widely used in studies to measure change in the severity of depression. There are reports of established reliability and validity of the HAMD in both inpatient and outpatient psychiatric patients. However, there are no published psychometric studies of the HAMD in a methamphetamine using population. Given that the symptoms of depression and intoxication or withdrawal from methamphetamine overlap, it is possible that the HAMD does not measure severity of depression in individuals who use methamphetamine. Thus, we are conducting a psychometric evaluation of the HAMD in methamphetamine users with and without depression. This evaluation is currently underway, and we anticipate having results in 6-8 weeks.Biography
Tracy L Hellem completed the PhD program at the University of Utah’s College of Nursing in 2015. She has worked with methamphetamine users with comorbid depression for 5 years. She has authored 14 manuscripts of systematic reviews, clinical trials and magnetic resonance spectroscopy studies. Dr. Hellem is an Assistant Professor at Montana State University’s College of Nursing where she conducts a clinical trial of comorbid depression and anxiety among individuals who use methamphetamine.
Email: tracy.hellem1@montana.edu
